Incluye referencias bibliográficas e índice

Foreword; Acknowledgement; Contents; List of Abbreviations ; Chapter 1: Introduction to Non-medical Prescribing: An Overview-Including Non-medical Prescribing in England; 1.1 Purpose of This Book; 1.2 Historical Perspective; 1.3 History Across the Four Countries; 1.4 Where We Are Now and Where We Are Going; 1.5 Continuing Professional Development (CPD); 1.6 Training and Assessment; References; Part I: Non-medical Prescribing in Scotland, Wales and Northern Ireland; Chapter 2: Non-medical Prescribing in Scotland; References

4.5 Independent Prescribing4.6 Curriculum and Training; 4.7 Scope of Practice; 4.8 Current Status in Primary and Secondary Care for Pharmacist Prescribers; 4.9 Current Status in Primary and Secondary Care for Nurse Prescribers; 4.10 Current Status in Primary and Secondary Care for Optometrist Prescribers; 4.11 Current Status in Primary and Secondary Care for Allied Health Professionals (Physiotherapist/Podiatrist or Chiropodist/Radiographer); 4.12 The Future of Non-medical Prescribing in NI; References; Part II: Non-medical Prescribing by Pharmacists and Allied Health Professionals

6.7 Radiography: Current Issues6.8 Undergraduate Education in Allied Health Prescribing: A Future Scenario?; 6.9 Conclusion; References; Part III: The Practice, Art and Discipline(s) of Non-medical Prescribing; Chapter 7: The Identity of Non-medical Prescribers; 7.1 Introduction; 7.2 Local Context; 7.3 Social Photo-Matrix; 7.4 Accountability and Governance; 7.5 Medicines Optimisation; 7.6 Therapeutic Relationship; 7.7 Community/Hospital Prescribing; References; Chapter 8: Non-medical Prescribing in Community Settings; 8.1 Introduction; 8.2 Medicines Optimisation; 8.3 Mobile Working

Chapter 3: Non-medical Prescribing in Wales: Implementation and Governance3.1 Implementation of Non-medical Prescribing: Nurse Prescribing Formulary; 3.2 Implementation of Supplementary Prescribing: Wales Context; 3.3 Implementation of Independent Prescribing: Wales Context; 3.4 Audit and Monitoring of Prescribing Data in Wales; 3.5 Clinical Governance: Continuing Professional Development; 3.6 Summary; References; Chapter 4: Non-medical Prescribing in Northern Ireland; 4.1 Introduction; 4.2 Supplementary Prescribing; 4.3 Curriculum and Training; 4.4 Scope of Practice

Chapter 5: Non-medical Prescribing by Pharmacists5.1 Genesis; 5.2 Implementation and Its Challenges; 5.3 Minor Ailments Schemes; 5.4 Pharmacists in GP Practices; References; Chapter 6: Prescribing by Designated Allied Health Professionals: The AHP Experience; 6.1 Introduction; 6.2 The Allied Health Professions; 6.3 Allied Health Independent Prescribing: Physiotherapy, Podiatry and Therapeutic Radiography; 6.4 Podiatry and Physiotherapy: Current Issues; 6.5 Independent Prescribing in Practice: Key Advantages; 6.6 Independent Prescribing in Practice: Disadvantages

This book explores key developments in Non-medical Prescribing in the UK. Addressing the needs of countries in the European Market and beyond, which have been closely watching UK developments and would be interested in embedding or developing counterparts of their own. Featuring chapters by clinicians, leaders and practitioners in the UK Non-medical Prescribing arena, it identifies both current and potential future developments. Attention is paid to the different prescribing practices and governance within the four countries constituting the United Kingdom. Many lessons have been learned along the way and the purpose of this book is to share these lessons, tog ether with best practice examples in connection with the implementation of nurse/health professional led patient care, implementation of patient centered practice, and governance. Designated Registered Practitioners who have completed an enhanced training now receive a professional body qualification which enables them to prescribe within their scope of practice as Non-medical Independent Prescribers and, providing that they are competent, from anywhere within the British National Formulary independently of doctors; for Nurses, this also includes most controlled drugs. The book will be of interest to policy makers and to forward-looking professionals and practitioners in the diverse European Health and Social Care market.